Literature DB >> 15708263

Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.

Eugene Wong1, David P D'Souza, Jeff Z Chen, Michael Lock, George Rodrigues, Terry Coad, Kris Trenka, Matt Mulligan, Glenn S Bauman.   

Abstract

PURPOSE: We developed an intensity-modulated arc therapy (IMAT) technique for the treatment of women with high-risk endometrial malignancies. In the context of multimodality therapy, nodal and tumor bed irradiation was delivered while respecting tolerance doses for critical structures. METHODS AND MATERIALS: Five patients were planned and treated with the IMAT technique after hysterectomy. Computed tomographic (CT) scans for treatment planning were acquired with the tumor bed contoured as the clinical target volume (CTV(tumor_bed)) and the iliac and presacral vessels contoured as the gross tumor volume (GTV). In 2 patients the lower para-aortic nodes were included into the GTV. The small bowel, iliac crests, femoral heads, bladder, and rectum were contoured as critical organs. For the nodes, a CTV(nodes) was generated with a 7-10-mm margin around the vessels, and the planning target volume (PTV(nodes)) was generated by a further 5-mm expansion. For the tumor bed, the PTV(tumor_bed) was generated with a margin of 7-10 mm around CTV(tumor_bed). Planning constraints included adequate coverage of the tumor bed (>95% receiving > or =45 Gy) and nodes (> or =95% receiving > or =40 Gy). Arc combinations with different extents were tested, and the final plan was generated based on the balance between complexity (number of arcs), PTV coverage, and critical structure sparing. Conventional and 8-field intensity-modulated radiation therapy (IMRT) plans were generated for each patient for comparison purposes. All patients were treated with IMAT.
RESULTS: We found that two anterior intensity-modulated arcs (300 degrees to 30 degrees and 330 degrees to 60 degrees ) adequately treated the PTVs. Furthermore, this IMAT technique allowed sparing of small bowel and the iliac crests (marrow space) to a similar degree as the 8-field IMRT. The 8-field IMRT yielded better dose uniformity than IMAT in the target volumes; however, neither technique was as uniform as the conventional plan. In the 5 patients, IMAT treatment was well tolerated and completed as planned.
CONCLUSIONS: We successfully piloted an optimized intensity-modulated arc technique to treat 5 high-risk endometrial cancer patients undergoing multimodality treatment. This allowed a significant reduction in dose to bone marrow and small bowel compared with conventional techniques and was simpler to deliver than multifield IMRT.

Entities:  

Mesh:

Year:  2005        PMID: 15708263     DOI: 10.1016/j.ijrobp.2004.06.253

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Analyzing the performance of ArcCHECK diode array detector for VMAT plan.

Authors:  Rajesh Thiyagarajan; Arunai Nambiraj; Sujit Nath Sinha; Girigesh Yadav; Ashok Kumar; Vikraman Subramani
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-02

3.  Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.

Authors:  Katrien Vandecasteele; Wilfried De Neve; Werner De Gersem; Louke Delrue; Leen Paelinck; Amin Makar; Valérie Fonteyne; Carlos De Wagter; Geert Villeirs; Gert De Meerleer
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

4.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

5.  Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer.

Authors:  Jason D Wright; Israel Deutsch; Elizabeth T Wilde; Cande V Ananth; Alfred I Neugut; Sharyn N Lewin; Zainab Siddiq; Thomas J Herzog; Dawn L Hershman
Journal:  Gynecol Oncol       Date:  2013-03-13       Impact factor: 5.482

6.  Effective Organs-at-Risk Dose Sparing in Volumetric Modulated Arc Therapy Using a Half-Beam Technique in Whole Pelvic Irradiation.

Authors:  Hyunsoo Jang; Jiyeon Park; Mark Artz; Yawei Zhang; Jacob C Ricci; Soon Huh; Perry B Johnson; Mi-Hwa Kim; Mison Chun; Young-Taek Oh; O Kyu Noh; Hae-Jin Park
Journal:  Front Oncol       Date:  2021-08-18       Impact factor: 6.244

7.  A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT).

Authors:  Florian Stieler; Dirk Wolff; Frank Lohr; Volker Steil; Yasser Abo-Madyan; Friedlieb Lorenz; Frederik Wenz; Sabine Mai
Journal:  Radiat Oncol       Date:  2009-10-25       Impact factor: 3.481

Review 8.  Clinical utility of RapidArc™ radiotherapy technology.

Authors:  Erminia Infusino
Journal:  Cancer Manag Res       Date:  2015-11-12       Impact factor: 3.989

9.  VMAT for the treatment of gynecologic malignancies for patients unable to receive HDR brachytherapy.

Authors:  Caitlin Merrow; Steven deBoer; Matthew B Podgorsak
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

10.  Comparing planning time, delivery time and plan quality for IMRT, RapidArc and Tomotherapy.

Authors:  Mike Oliver; Will Ansbacher; Wayne A Beckham
Journal:  J Appl Clin Med Phys       Date:  2009-10-07       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.